GATA-3 expression identifies a subset of PTCL, NOS with inferior survival. Kaplan-Meier estimates of progression-free and overall survival are shown for PTCL, NOS patients stratified by GATA-3 expression (dashed line, GATA-3 positive; solid line, GATA-3 negative).